Antineoplaston AS-2-1

AS-2-1 · Burzynski Research Institute

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Antineoplaston AS-2-1, covering 2018-05-09 to 2018-05-09. Get the full timeline:

Most recent: Clinical Trial Update: Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer [Phase 2]